Form 4: Hims & Hers Health CFO Oluyemi Okupe Sells Shares Under 10b5-1 Trading Plan

Oluyemi Okupe, CFO of Hims & Hers Health, Inc., sold 23,118 shares of Class A Common Stock at an average price of $32.4066 on March 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 21, 2025, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., sold 23,118 shares of Class A Common Stock.
• The sale was executed at an average price of $32.4066 per share.
• The transactions were conducted under a Rule 10b5-1 trading plan adopted on May 31, 2024.
• Following the reported transaction, Okupe directly owns 129,248 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a change in the CFO's confidence in the company.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned through Rule 10b5-1 trading plans to avoid accusations of trading on non-public information. The market typically analyzes the size and frequency of such sales to gauge insider sentiment.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a common practice among executives at publicly traded companies, including those in the telehealth sector like Teladoc Health and Amwell.
• The volume of shares sold is relatively small compared to the total outstanding shares of Hims & Hers Health, suggesting it may be part of routine portfolio management rather than a significant shift in sentiment.
• Comparable insider sales at similar companies are often scrutinized based on the percentage of their holdings sold and the timing relative to company announcements.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, potentially leading to slight downward pressure on the stock price in the short term.
• However, the existence of a 10b5-1 trading plan mitigates concerns about insider trading and suggests the sale was pre-planned.

Key Dates

Keywords

Hims & Hers Health, Oluyemi Okupe, CFO, stock sale, Form 4, Rule 10b5-1, insider trading, HIMS